We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Offering people the opportunity to experience boating through a boat charter marketplace via a mobile app. Borrow A Boat allows customers to book a peer-to-peer or commercial boat near them from anywhere in the world. Boats and watercrafts listed on the platform range from stand-up paddleboards to superyachts. Borrow A Boat lists over 16,000 boats on their marketplace, including boats from private owners. The service is available in 60 countries, with the option of renting the same day.
days to go: Expired investment: £1,496,600
Tribal Sports Nutrition (TSN) uses the revitalising properties of the Baobab fruit to create energy smoothies. TSN claims that its smoothies are less concentrated than other sports nutrition brands, are 100% organic, and easy on the stomach. The company also incorporates vitamin C, antioxidants, fibre, and electrolytes into the smoothies to make it the on-the-go snack for active lifestyle consumers. TSN asserts that its baobab ingredient is wild-harvested by cooperatives in Africa, bringing income to people and preserving the local ecology. The company received a certification from the Organic Food Federation (OFF) and aims to achieve B Corp status. TSN's products have been listed in Sainsbury's and on Amazon. It will use the investment to double its existing product offering in 2021 and launch hydration, plant protein recovery products, and Baobab energy snacks.

Pitch Rated

86%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £421,647
Velorution is an electrical cycling retailer with products designed for urban environments. They currently own 3 stores with a combined turnover of £500k. The company is raising funds to grow their business by increasing the number of permanent retail locations in 2019. In addition, they are planning to increase brand awareness by partnering with other businesses. Current collaborations include Selfridges and Lululemon, where Velorution cycles are showcased at their concessions and pop-up venues.
days to go: Expired investment: £543,090
Integumen is a personal health company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes.
days to go: Expired investment: £2,160,000
Doctaly is  the brand new healthcare platform providing the quickest way to find and book an affordable, face-to-face, same day GP appointment. Choose from their trusted private doctors, at a convenient time and location from just £39.99.
days to go: Expired investment: £807,580
One of the largest automotive communities’ worldwide, attracting millions of car fans every week. Lovecars focuses on the luxury car market and generates revenue from partnerships with Rolls-Royce Motor Cars by utilising their social media reach. The company aims to bring car sales into the modern digital age by allowing its highly engaged community to review, rate and buy cars online.
days to go: Expired investment: £178,380
Birchwood Marine is one of the best British brands in the boat manufacturing business. It has a dedicated team of loyal dealers and has over 5000 boats to its credit. The company has an M.O.U Agreement with a reputed and established manufacturer in Argentina. It is also planning to re-launch Birchwood by using a joint-venture manufacturing association and produce a range of Sport Express and Flybridge models (from 34ft to 74ft), which will be sold in the US, EU, the UK, the UAE and China market. With the proceeds, the company will purchase two more boats for the forthcoming Southampton In-Water Boat Show, 2019 and the Dusseldorf Indoor Show, 2020.
days to go: Expired investment: £82,140
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph